Randomized, Placebo-Controlled, Esophageal Squamous Cell Cancer Chemoprevention Trial of Selenomethionine and Celecoxib
To access this article, please choose from the options below
Supported by National Cancer Institute (NCI) contract N01-RC-91019. P.J.L. was an NCI Cancer Prevention Fellow at the time the study was initiated and was further supported in part by NCI Career Development Award K07-CA-92216 after becoming a faculty member at the Mayo Clinic College of Medicine.
The authors have no conflicts of interest to report. The corresponding author had full access to the data in the study and had final responsibility for the decision to submit for publication.
PII: S0016-5085(05)01126-1
doi:10.1053/j.gastro.2005.06.024
© 2005 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.

